RGPD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.65894031423886E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.04649955368075E-10 |
Normal-vs-Stage2 |
5.63649999999472E-05 |
Normal-vs-Stage3 |
2.88657986402541E-15 |
Normal-vs-Stage4 |
1.65401026208656E-12 |
Stage1-vs-Stage2 |
8.469200E-01 |
Stage1-vs-Stage3 |
7.575400E-03 |
Stage1-vs-Stage4 |
1.559700E-03 |
Stage2-vs-Stage3 |
2.187200E-01 |
Stage2-vs-Stage4 |
8.987900E-02 |
Stage3-vs-Stage4 |
3.846800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.6503465261053E-12 |
Normal-vs-AfricanAmerican |
2.36149999555124E-08 |
Normal-vs-Asian |
4.555900E-02 |
Caucasian-vs-AfricanAmerican |
8.498200E-01 |
Caucasian-vs-Asian |
4.486600E-01 |
AfricanAmerican-vs-Asian |
4.240000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-15 |
Normal-vs-Female |
1.24739996110179E-09 |
Male-vs-Female |
6.419900E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.35120000030764E-08 |
Normal-vs-Age(41-60Yrs) |
1.71780034641245E-10 |
Normal-vs-Age(61-80Yrs) |
1.63991042967382E-12 |
Normal-vs-Age(81-100Yrs) |
3.13829999998294E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.429550E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.426600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.921000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.677600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.985000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.932000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.079800E-02 |
Normal-vs-Grade 2 |
1.19040000079451E-09 |
Normal-vs-Grade 3 |
1.62458935193399E-12 |
Normal-vs-Grade 4 |
1.6725509865978E-12 |
Grade 1-vs-Grade 2 |
4.504600E-01 |
Grade 1-vs-Grade 3 |
5.184200E-02 |
Grade 1-vs-Grade 4 |
1.513720E-02 |
Grade 2-vs-Grade 3 |
4.295800E-03 |
Grade 2-vs-Grade 4 |
1.636400E-03 |
Grade 3-vs-Grade 4 |
1.940160E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
6.19320039696447E-10 |
Normal-vs-ccB subtype |
1.0439005215801E-10 |
ccA subtype-vs-ccB subtype |
1.553220E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.6175951123596E-11 |
Normal-vs-N1 |
1.02489999997957E-06 |
N0-vs-N1 |
1.807440E-01 |
|
|